proqolid

Home > Instruments > EORTC Quality of Life Questionnaire - Core Questionnaire (EORTC QLQ-C30)

EORTC Quality of Life Questionnaire - Core Questionnaire (EORTC QLQ-C30)

Developed in 1988

The EORTC QLQ-C30 is a core generic questionnaire associated with different disease specific modules

  

Modules described in PROQOLID:

Bone Metastases EORTC QLQ-BM22

Brain cancer EORTC QLQ-BN20

Breast cancer EORTC QLQ-BR23

Cervical cancer EORTC QLQ-CX24

Head & Neck cancer EORTC QLQ-H&N35

Hepatocellular Carcinoma EORTC QLQ-HCC18

Lung cancer EORTC QLQ-LC13

Multiple Myeloma EORTC QLQ-MY20

Ovarian cancer EORTC QLQ-OV28

Prostate cancer EORTC QLQ-PR25

  

Access the complete module list on the EORTC Quality of Life website

Author(s)

EORTC Quality of Life Group

© Copyright 1995 EORTC Quality of Life Group. All rights reserved. Version 3.0

Purpose

  • Pathology:

Neoplasms

  • Disease:

Generic for neoplasms

  • Objective:

It has been designed for use in a wide range of cancer patient populations, and is intended to be supplemented by more specific questionnaire modules

  • Population for intended use:

Adult

 

Characteristics

  • Concept of interest:

Health-Related Quality of Life - HRQL (incl. health status)

  • Administration mode:

Self-administered

  • Data collection mode:

Paper and pen

[ Interviewer administration is possible, with the reservation that this should be validated for each questionnaire used in that way ]

  • Number of items:

30 items

  • Recall/Observation period:

During the past week

 

Bibliographic reference(s) of the original questionnaire

Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res. 1988;111:231-49

Aaronson NK, Ahmedzai S, Bullinger M, Crabeels D, Estape J, Filiberti AN et al. The EORTC Core Quality of Life Questionnaire : Interim Results of an International Field Study. In: OSOBA D, editor. Effect of Cancer on Quality of Life. Vancouver: 1991: 185-202

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85:365-76 (PubMed abstract)

Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol. 1995 May;13(5):1249-54 (PubMed abstract)

King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res. 1996 Dec;5(6):555-67. Review (PubMed abstract)

Osoba D, Aaronson N, Zee B, Sprangers M, te Velde A. Modification of the EORTC QLQ-C30 (version 2.0) based on content validity and reliability testing in large samples of patients with cancer. The Study Group on Quality of Life of the EORTC and the Symptom Control and Quality of Life Committees of the NCI of Canada Clinical Trials Group. Qual Life Res. 1997 Mar;6(2):103-8 (PubMed abstract)

Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998 Jan;16(1):139-44 (PubMed abstract)

Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, Ahlner-Elmqvist M, Maher EJ, Meyza JW, Brédart A, Söderholm AL, Arraras JJ, Feine JS, Abendstein H, Morton RP, Pignon T, Huguenin P, Bottomly A, Kaasa S. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer. 2000 Sep;36(14):1796-807 (PubMed abstract)

Language(s)

  • Original language:

English

  • List of existing translations:

Please refer to Translations tab or contact us

To access this information, please sign in or subscribe to PROQOLID database

To access this information, please sign in or subscribe to PROQOLID database

To access this information, please sign in or subscribe to PROQOLID database

To access this information, please sign in or subscribe to PROQOLID database

To access this information, please sign in or subscribe to PROQOLID database

To access this information, please sign in or subscribe to PROQOLID database

Last update: November 2013

  

For additional information on this instrument, please contact our Information Support Unit